144 related articles for article (PubMed ID: 29050325)
1. Toll-like receptor 3 pathway restricts Marek's disease virus infection.
Zou H; Su R; Ruan J; Shao H; Qian K; Ye J; Qin A
Oncotarget; 2017 Sep; 8(41):70847-70853. PubMed ID: 29050325
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Marek's Disease Virus Infection by Toll-Like Receptor Ligands in Chicken Embryo Fibroblast Cells.
Bavananthasivam J; Kulkarni RR; Read L; Sharif S
Viral Immunol; 2018 Jun; 31(5):389-396. PubMed ID: 29570417
[TBL] [Abstract][Full Text] [Related]
3. Activation of Toll-like receptor 3 inhibits Marek's disease virus infection in chicken embryo fibroblast cells.
Hu X; Zou H; Qin A; Qian K; Shao H; Ye J
Arch Virol; 2016 Mar; 161(3):521-8. PubMed ID: 26597188
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of Toll-like receptor pathway genes in chicken embryo fibroblasts from chickens resistant and susceptible to Marek's disease.
Haunshi S; Cheng HH
Poult Sci; 2014 Mar; 93(3):550-5. PubMed ID: 24604847
[TBL] [Abstract][Full Text] [Related]
5. In ovo administration of Toll-like receptor ligands encapsulated in PLGA nanoparticles impede tumor development in chickens infected with Marek's disease virus.
Bavananthasivam J; Alkie TN; Astill J; Abdul-Careem MF; Wootton SK; Behboudi S; Yitbarek A; Sharif S
Vaccine; 2018 Jun; 36(28):4070-4076. PubMed ID: 29859800
[TBL] [Abstract][Full Text] [Related]
6. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
[TBL] [Abstract][Full Text] [Related]
7. Immune Responses in Cecal Tonsils of Marek's Disease Virus-Infected Chickens.
Heidari M; Fitzgerald SD; Zhang H
Avian Dis; 2015 Jun; 59(2):213-26. PubMed ID: 26473671
[TBL] [Abstract][Full Text] [Related]
8. Marek's disease virus may interfere with T cell immunity by TLR3 signals.
Hu X; Xu W; Qin A; Wu G; Qian K; Shao H; Ye J
Vet Res Commun; 2014 Jun; 38(2):149-56. PubMed ID: 24585377
[TBL] [Abstract][Full Text] [Related]
9. The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek's disease in chickens.
Parvizi P; Abdul-Careem MF; Mallick AI; Haq K; Haghighi HR; Orouji S; Heidari M; Behboudi S; Sharif S
Vaccine; 2014 Apr; 32(17):1932-8. PubMed ID: 24530927
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Toll-like receptor genes in lymphoid tissues between Marek's disease virus-infected and noninfected chickens.
Jie H; Lian L; Qu LJ; Zheng JX; Hou ZC; Xu GY; Song JZ; Yang N
Poult Sci; 2013 Mar; 92(3):645-54. PubMed ID: 23436515
[TBL] [Abstract][Full Text] [Related]
11. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling.
Heidari M; Sarson AJ; Huebner M; Sharif S; Kireev D; Zhou H
Viral Immunol; 2010 Jun; 23(3):309-19. PubMed ID: 20565294
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A regulates TLR2/4-mediated IFN-β signaling pathway against Marek's disease virus.
Yang J; Yang K; Wang K; Zhou D; Zhou J; Du X; Liu S; Cheng Z
Virus Res; 2023 Mar; 326():199044. PubMed ID: 36652973
[TBL] [Abstract][Full Text] [Related]
13. Immunity to Marek's disease: where are we now?
Haq K; Schat KA; Sharif S
Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling of Marek's disease virus infection in host cell based on untargeted LC-MS.
Wang Q; Shi B; Yang G; Zhu X; Shao H; Qian K; Ye J; Qin A
Front Microbiol; 2023; 14():1270762. PubMed ID: 38029131
[TBL] [Abstract][Full Text] [Related]
15. Marek's disease virus type 1 encoded analog of miR-155 promotes proliferation of chicken embryo fibroblast and DF-1 cells by targeting hnRNPAB.
Dang L; Teng M; Li HZ; Ma SM; Lu QX; Hao HF; Zhao D; Zhou EM; Zhang GP; Luo J
Vet Microbiol; 2017 Aug; 207():210-218. PubMed ID: 28757026
[TBL] [Abstract][Full Text] [Related]
16. [Study of the vaccinating properties of 2 variants of Marek's disease virus].
Iakovleva LS; Merekalova ZI; Pavlovskaia AI; Plakhov IV; Mazurenko NP
Vopr Virusol; 1977; (4):493-6. PubMed ID: 200016
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of Marek's disease viruses having green fluorescent protein expression tied directly or indirectly to phosphoprotein 38 expression.
Prigge JT; Majerciak V; Hunt HD; Dienglewicz RL; Parcells MS
Avian Dis; 2004 Sep; 48(3):471-87. PubMed ID: 15529969
[TBL] [Abstract][Full Text] [Related]
18. Marek's Disease Virus Activates the PI3K/Akt Pathway Through Interaction of Its Protein Meq With the P85 Subunit of PI3K to Promote Viral Replication.
Li H; Zhu J; He M; Luo Q; Liu F; Chen R
Front Microbiol; 2018; 9():2547. PubMed ID: 30405592
[TBL] [Abstract][Full Text] [Related]
19. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
[TBL] [Abstract][Full Text] [Related]
20. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus.
Wu P; Lee LF; Reed WM
Avian Dis; 1997; 41(4):824-31. PubMed ID: 9454915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
